{
  "main_header": {
    "sid": 476417,
    "name": "Coral Labs.",
    "stock_name": "Coral Labs.",
    "full_name": "Coral Laboratories Ltd",
    "name_url": "stocks-analysis/coral-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "647.00",
    "chg": -23,
    "chgp": "-3.43%",
    "dir": -1,
    "prev_price": "670.00",
    "mcapval": "231.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524506,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE683E01017",
    "curr_date": "Apr 11, 12:50 PM",
    "curr_time": "00:06 AM",
    "bse_nse_vol": "1.4 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/coral-labs-476417-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Coral Laboratories Reports Strong Profit Growth Amid Operational Efficiency Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-reports-strong-financial-growth-amid-downgrade-to-hold-status-1270258",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/CoralLaboratori_mojoScore_637027.png",
        "date": "2025-03-11 08:11:15",
        "description": "Coral Laboratories, a microcap in the Pharmaceuticals & Drugs sector, has recently experienced a score adjustment reflecting its financial performance. In Q3 FY24-25, the company reported substantial growth in operating and net profits, alongside a notable increase in net sales, despite challenges in management efficiency."
      },
      {
        "title": "Coral Laboratories Outperforms Sensex with Strong Yearly Gains Amid Market Fluctuations",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/coral-laboratories-ltd-achieves-87-03-growth-amidst-flat-sensex-performance-1516461",
        "imagepath": "",
        "date": "2025-03-10 18:00:15",
        "description": "Coral Laboratories Ltd, a microcap player in the Pharmaceuticals & Drugs industry, has shown significant performance over the past year, boasting an impressive 87.03% increase, while the broader Sensex has remained nearly flat at -0.01%. Despite a slight decline of 2.81% today, Coral Laboratories has demonstrated resilience with a 2.77% gain over the past week, contrasting with the Sensex's 1.41% rise.\n\nThe company's market capitalization stands at Rs 282.00 crore, with a price-to-earnings (P/E) ratio of 9.99, significantly lower than the industry average of 35.87. This indicates a potentially attractive valuation relative to its peers. Over the longer term, Coral Laboratories has excelled, with a remarkable 467.59% increase over the past five years, outpacing the Sensex's 107.98% growth during the same period.\n\nTechnical indicators present a mixed picture, with the weekly MACD showing a mildly bearish tren..."
      },
      {
        "title": "Coral Laboratories Reports Strong Financial Growth in December 2024 Results",
        "link": "https://www.marketsmojo.com/news/result-analysis/coral-laboratories-reports-259-63-growth-in-profit-before-tax-for-december-2024-1009371",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/CoralLaboratori_quaterlyResult_441949.png",
        "date": "2025-02-14 09:57:51",
        "description": "Coral Laboratories has announced its financial results for the quarter ending December 2024, showcasing significant growth. Profit Before Tax reached Rs 5.79 crore, while Profit After Tax was Rs 6.14 crore. Net sales totaled Rs 22.99 crore, indicating positive trends in profitability and operational effectiveness."
      }
    ],
    "total": 34,
    "sid": "476417",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/coral-laboratories-476417"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "08-Apr-2025",
      "details": "Certificate under Reg.74(5) of SEBI (DP) Regulations 2018",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "24-Mar-2025",
      "details": "This is to inform you that pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 and as per the Companys Code of Conduct to regulate monitor and report trading by insiders (Code) the Trading Window for dealing in the securities of the Company will be closed for all the Designated Persons and their relatives from Tuesday April 01 2025 till 48 (forty eight) hours after declaration of unaudited standalone financial results for the quarter and financial year ended March 31 2025. The trading window shall open after 48 hours of declaration of the said results. The date of the Board meeting to consider inter alia unaudited standalone financial results for the quarter and financial year ended March 31 2025 shall be intimated separately in due course.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Feb-2025",
      "details": "Pursuant to Regulation 33 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed copies of newspaper advertisement pertaining to Standalone Unaudited standalone financial results of the Company for the quarter and nine month ended December 31 2024.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Coral Laboratories Ltd has declared <strong>20%</strong> dividend, ex-date: 20 Sep 24",
          "dt": "2024-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Coral Laboratories Reports Strong Profit Growth Amid Operational Efficiency Challenges

2025-03-11 08:11:15

Coral Laboratories, a microcap in the Pharmaceuticals & Drugs sector, has recently experienced a score adjustment reflecting its financial performance. In Q3 FY24-25, the company reported substantial growth in operating and net profits, alongside a notable increase in net sales, despite challenges in management efficiency.

Read More

Coral Laboratories Outperforms Sensex with Strong Yearly Gains Amid Market Fluctuations

2025-03-10 18:00:15

Coral Laboratories Ltd, a microcap player in the Pharmaceuticals & Drugs industry, has shown significant performance over the past year, boasting an impressive 87.03% increase, while the broader Sensex has remained nearly flat at -0.01%. Despite a slight decline of 2.81% today, Coral Laboratories has demonstrated resilience with a 2.77% gain over the past week, contrasting with the Sensex's 1.41% rise. The company's market capitalization stands at Rs 282.00 crore, with a price-to-earnings (P/E) ratio of 9.99, significantly lower than the industry average of 35.87. This indicates a potentially attractive valuation relative to its peers. Over the longer term, Coral Laboratories has excelled, with a remarkable 467.59% increase over the past five years, outpacing the Sensex's 107.98% growth during the same period. Technical indicators present a mixed picture, with the weekly MACD showing a mildly bearish tren...

Read More

Coral Laboratories Reports Strong Financial Growth in December 2024 Results

2025-02-14 09:57:51

Coral Laboratories has announced its financial results for the quarter ending December 2024, showcasing significant growth. Profit Before Tax reached Rs 5.79 crore, while Profit After Tax was Rs 6.14 crore. Net sales totaled Rs 22.99 crore, indicating positive trends in profitability and operational effectiveness.

Read More

View All News